09:36 AM EDT, 05/08/2024 (MT Newswires) -- Avadel Pharmaceuticals ( AVDL ) reported a Q1 net loss Wednesday of $0.30 per diluted share, narrowing from a loss of $0.48 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.23.

Net product revenue for the quarter ended March 31 was $27.2 million. The company didn't provide a figure for the previous year.

Analysts surveyed by Capital IQ expected revenue of $25.9 million.

Price: 16.01, Change: -2.17, Percent Change: -11.94